Abbott Resets Nutrition While Expanding Diagnostics And Device Growth Drivers
Abbott Laboratories (NYSE:ABT) is addressing ongoing headwinds in its Nutrition segment with changes to pricing, promotions, and cost structures, with a shift signaled to begin in the fourth quarter. The company is moving ahead with…




